스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - posaconazolum - suspension buvable - posaconazolum 40 mg, polysorbatum 80, glucose liquide, arom.: vanillinum et d'autres, conserv.: e 211, l'alcool benzylicus, excipiens à la suspension pour 1 ml. - les infections fongiques - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum - comprimés pelliculés - sitagliptinum 25 mg ut sitagliptini phosphas monohydricus, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 0.4 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum - comprimés pelliculés - sitagliptinum 50 mg ut sitagliptini phosphas monohydricus, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 0.78 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum, natrium - comprimés pelliculés - sitagliptinum 100 mg ut sitagliptini phosphas monohydricus, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 1.57 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - raltegravirum - comprimés pelliculés - raltegravirum 400 mg ut raltegravirum kalicum, cellulosum microcristallinum, lactosum monohydricum 26.1 mg, dikalii phosphas anhydricus, hypromellosum, poloxamerum 407, natrii stearylis fumaras, magnesii stearas, e 321, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 510 µg. - les infections à vih - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg ut sitagliptini phosphas monohydricus, metformini hydrochloridum 500 mg, cellulosum microcristallinum, povidonum k 29-32, natrii stearylis fumaras, natrii laurilsulfas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.08 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg ut sitagliptini phosphas monohydricus, metformini hydrochloridum 850 mg, cellulosum microcristallinum, povidonum k 29-32, natrii stearylis fumaras, natrii laurilsulfas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.77 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptinum 50 mg ut sitagliptini phosphas monohydricus, metformini hydrochloridum 1000 mg, cellulosum microcristallinum, povidonum k 29-32, natrii stearylis fumaras, natrii laurilsulfas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.05 mg. - antidiabétique oral utilisé - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - raltegravirum - comprimés à croquer - raltegravirum 25 mg ut raltegravirum kalicum, hydroxypropylcellulosum, sucralosum, saccharinum natricum, natrii citras dihydricus, mannitolum, ammonii glycyrrhizas corresp. fructosum 0.54 mg et sorbitolum 1.47 mg, crospovidonum, magnesii stearas, natrii stearylis fumaras, ethylcellulosum, triglycerida media, acidum oleicum, Überzug: hypromellosum, macrogolum 400, e 172 (flavum), aromatica bananenaroma corresp. saccharum 3.5 mg, aromatica orangenaroma, aromatica maskierungsaroma corresp. saccharum 3.5 mg et aspartamum 0.47 mg, pro compresso corresp. natrium 1.19 mg. - l'infection à vih - synthetika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - raltegravirum - comprimés à croquer - raltegravirum 100 mg ut raltegravirum kalicum, hydroxypropylcellulosum, sucralosum, saccharinum natricum, natrii citras dihydricus, mannitolum, ammonii glycyrrhizas corresp. fructosum 1.07 mg et sorbitolum 2.94 mg, crospovidonum, magnesii stearas, natrii stearylis fumaras, ethylcellulosum, triglycerida media, acidum oleicum, Überzug: hypromellosum, macrogolum 400, e 172 (rubrum), e 172 (flavum), aromatica bananenaroma corresp. saccharum 7 mg, aromatica orangenaroma, aromatica maskierungsaroma corresp. saccharum 7 mg et aspartamum 0.93 mg, pro compresso corresp. natrium 2.4 mg. - l'infection à vih - synthetika